Improvement of Postoperative Immunosuppression in Patients Receiving Coronary Artery Bypass Grafting by TEAS
1 other identifier
interventional
88
1 country
1
Brief Summary
The coronary artery bypass grafting (CABG) is a surgery to relieve angina and reduce mortality of coronary heart disease. However, the patient is more prone to have immunosuppression after the surgery, causing secondary infection, and it is closely correlated to the occurrence and progress of tumor after surgery. More and more studies revealed that needle puncture was able to effectively regulate the function of immune system. However, its perioperative application is unclear. Therefore, this clinical study is aimed to evaluate whether the effect of transcutaneous acupoint electric stimulation (TEAS) on improvement of immunosuppression of patients after receiving CABG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2016
CompletedFirst Posted
Study publicly available on registry
October 14, 2016
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedMay 27, 2020
May 1, 2020
2.2 years
October 10, 2016
May 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of mHLA-DR positive cell
Human leukocyte antigen of monocyte (mHLA-DR)
day before surgery, Day 1 after surgery (one day after surgery), Day 3 after surgery (3 days after surgery), and Day 5 after surgery (5 days after surgery).
Secondary Outcomes (3)
Content of serum IL-6
One day before surgery, Day 1, 3 and 5 after surgery
Content of serum CRP
One day before surgery, Day 1, 3 and 5 after surgery
Rate of secondary infection
Within 7 days after surgery
Study Arms (2)
TEAS+GA group
EXPERIMENTALThe patients of TEAS+GA group will receive TEAS therapy in perioperative period. GA: general anesthesia
Sham TEAS+GA group
SHAM COMPARATORThe patients of Sham TEAS+GA will receive none TEAS in perioperative period.
Interventions
The acupoints including Zusanli and Shenshu, were identified before electrical stimulation with surface electrodes. Selection of these acupoints was based on a consensus between the acupuncturists of the study.
No electrical stimulation sensation is performed in the Sham TEAS group. In the Sham TEAS group, pseudo-stimulation is provided by deliberately connecting the electrodes to the incorrect output socket of the electroacupuncture device, and thus there is no flow of electric current. Patients could see the output light flashing but no current was transmitted throughout the procedure. Patients would be told that the stimulation frequency selected was not perceivable by human beings.
Eligibility Criteria
You may qualify if:
- Aged 18-75 years, male and female;
- Patients diagnosed as coronary disease, scheduled to receive CABG;
- BMI: 18.5kg/m2\<BMI≤30kg/m2;
- Graded as I-III by American Standards Association(ASA);
- Patients firstly receiving CABG under extracorporeal circulation.
You may not qualify if:
- Presence of surgical incision or scar at Zusanli acupoint (ST36) /Shenshu (BL23) acupoint;
- Patients with local skin infection at acupoint;
- Patients with nerve injury on upper or lower limbs;
- Patients with history of spinal surgery;
- Patients who have participated in other clinical trial in recent 4 weeks;
- Patients using pacemaker;
- Patients combined with pain before surgery who are using central analgesic drug or drug abuser (e.g., opioid) and dependent user;
- Patients combined with severe central nervous system disease or severe mental disease;
- Patients with alcoholic history;
- Patients who have received emergent coronary bypass operation due to acute myocardial infarction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ShuGuang Hospitallead
- Guangdong Provincial People's Hospitalcollaborator
Study Sites (1)
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, 201203, China
Related Publications (1)
Chen WT, Wei JF, Wang L, Zhang DW, Tang W, Wang J, Yong Y, Wang J, Zhou YL, Yuan L, Fu GQ, Wang S, Song JG. Effects of perioperative transcutaneous electrical acupoint stimulation on monocytic HLA-DR expression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass: study protocol for a double-blind randomized controlled trial. Trials. 2019 Dec 30;20(1):789. doi: 10.1186/s13063-019-3889-z.
PMID: 31888744DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jianggang Song, M.D.
Shuguang Hospital Affiliated to Shanghai University of TCM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- deputy director of anesthesia
Study Record Dates
First Submitted
October 10, 2016
First Posted
October 14, 2016
Study Start
December 1, 2017
Primary Completion
February 29, 2020
Study Completion
March 31, 2020
Last Updated
May 27, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data will become available with 6 months of study completion.
- Access Criteria
- Data access requests will be reviewed by an extemal independent Review Panel. Requestors will be required to sign a Data Access Agreement.
Study Protocol will be shared with other researchers.